Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales: Teng, Fei, Zhang, Ju-Xiang, Chang, Qi-Meng, Wu, Xu-Bo, Tang, Wei-Guo, Wang, Jian-Fa, Feng, Jin-Feng, Zhang, Zi-Ping, Hu, Zhi-Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542228/
https://www.ncbi.nlm.nih.gov/pubmed/37775828
http://dx.doi.org/10.1186/s13046-023-02824-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542228/
https://www.ncbi.nlm.nih.gov/pubmed/37775828
http://dx.doi.org/10.1186/s13046-023-02824-9

Ejemplares similares